Subversion of Host Defense Mechanisms by Adenoviruses
10.1007/978-3-642-59421-2_16
Crossref book-chapter
Springer Berlin Heidelberg
Current Topics in Microbiology and Immunology (297)
Bibliography

Burgert, H.-G., Ruzsics, Z., Obermeier, S., Hilgendorf, A., Windheim, M., & Elsing, A. (2002). Subversion of Host Defense Mechanisms by Adenoviruses. Viral Proteins Counteracting Host Defenses, 273–318.

Authors 6
  1. H.-G. Burgert (first)
  2. Z. Ruzsics (additional)
  3. S. Obermeier (additional)
  4. A. Hilgendorf (additional)
  5. M. Windheim (additional)
  6. A. Elsing (additional)
References 213 Referenced 36
  1. Anderson KP, Fennie EH (1987) Adenovirus early region 1A modulation of interferon antiviral activity. J Virol 61:787–795 (10.1128/JVI.61.3.787-795.1987) / J Virol by KP Anderson (1987)
  2. Andersson M, Pääbo S, Nilsson T, Peterson PA (1985) Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43:215–222 (10.1016/0092-8674(85)90026-1) / Cell by M Andersson (1985)
  3. Andrade F, Bull HG, Thornberry NA, Ketner GW, Casciola-Rosen LA, Rosen A (2001) Adenovirus L4–100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death. Immunity 14:751–761 (10.1016/S1074-7613(01)00149-2) / Immunity by F Andrade (2001)
  4. Arany Z, Newsome D, Oldread E, Livingston D, Eckner R (1995) A family of transcriptional adaptor proteins targeted by the El A oncoprotein. Nature 374:81–84 (10.1038/374081a0) / Nature by Z Arany (1995)
  5. Ashcroft M, Vousden KH (1999) Regulation of p53 stability. Oncogene 18:7637–7643 (10.1038/sj.onc.1203012) / Oncogene by M Ashcroft (1999)
  6. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305–1308 (10.1126/science.281.5381.1305) / Science by A Ashkenazi (1998)
  7. Basler CF, Droguett G, Horwitz MS (1996) Sequence of the immunoregulatory early region-3 and flanking sequences of adenovirus type-35. Gene 170:249–254 (10.1016/0378-1119(95)00898-5) / Gene by CF Basler (1996)
  8. Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717–1725 (10.1056/NEJM199606273342607) / N Engl J Med by F Bazzoni (1996)
  9. Beard CW, Spindler KR (1995) Characterization of an 1 IK protein produced by early region 3 of mouse adenovirus type 1. Virology 208:457–466 (10.1006/viro.1995.1176) / Virology by CW Beard (1995)
  10. Benedict CA, Norris PS, Prigozy TI, Bodmer J-L, Mahr JA, Garnett CT, Martinon F, Tschopp J, Gooding LR, Ware CF (2001) Three adenovirus E3 proteins cooperate to evade apoptosis by TRAIL receptor-1 and 2. J Biol Chem 276:3270–3278 (10.1074/jbc.M008218200) / J Biol Chem by CA Benedict (2001)
  11. Bennett EM, Bennink JR, Yewdell JW, Brodsky FM (1999) Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J Immunol 162:5049–5052 (10.4049/jimmunol.162.9.5049) / J Immunol by EM Bennett (1999)
  12. Bergelson J, Cunningham J, Droguett G, Kurt-Jones E, Krithivas A, Hong J, Horwitz M, Crowell R, Finberg R (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323 (10.1126/science.275.5304.1320) / Science by J Bergelson (1997)
  13. Bewley MC, Springer K, Zhang YB, Freimuth P, Flanagan JM (1999) Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 286:1579–1583 (10.1126/science.286.5444.1579) / Science by MC Bewley (1999)
  14. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D’Andrea A, Livingston DM (1996) Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383:344–347 (10.1038/383344a0) / Nature by S Bhattacharya (1996)
  15. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17:189–220 (10.1146/annurev.immunol.17.1.189) / Annu Rev Immunol by CA Biron (1999)
  16. Blair GE, Hall KT (1998) Human adenoviruses: Evading detection by cytotoxic T lymphocytes. Semin Virol 8:387–397 (10.1006/smvy.1997.0140) / Semin Virol by GE Blair (1998)
  17. Borgland S, Bowen G, Wong N, Libermann T, Muruve D (2000) Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-KB. J Virol 74:3941–3947 (10.1128/JVI.74.9.3941-3947.2000) / Virol by S Borgland (2000)
  18. Bosse D, Ades E (1991) Studies of adenovirus subtypes and down-regulation of HLA class I expression: correlations to natural-killer-mediated cytolysis. Pathobiology 59:313–315 (10.1159/000163669) / Pathobiology by D Bosse (1991)
  19. Boulakia C, Chen G, Ng F, Teodoro J, Branton P, Nicholson D, Poirier G, Shore G (1996) Bcl-2 and adenovirus E1B 19kDa protein prevent ElA-induced processing of CPP32 and cleavage of poly (ADP-ribose) polymerase. Oncogene 12:529–535 / Oncogene by C Boulakia (1996)
  20. Boyd J, Malstrom S, Subramanian T, Venkatesh L, Schaeper U, Elangovan B, D’Sa-Eipper C, Chinnadurai G (1994) Adenovirus E1B 19kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79:341–351 (10.1016/0092-8674(94)90202-X) / Cell by J Boyd (1994)
  21. Bruder JT, Jie T, McVey DL, Kovesdi I (1997) Expression of gpl9K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver. J Virol 71:7623–7628 (10.1128/JVI.71.10.7623-7628.1997) / J Virol by JT Bruder (1997)
  22. Bruder JT, Kovesdi I (1997) Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol 71:398–404 (10.1128/JVI.71.1.398-404.1997) / J Virol by JT Bruder (1997)
  23. Burgert H-G (1996) Subversion of the MHC class I antigen presentation pathway by adenoviruses and herpes simplex viruses. Trends Microbiol 4:107–112 (10.1016/0966-842X(96)81527-7) / Trends Microbiol by HG Burgert (1996)
  24. Burgert H-G, Blusch J (2000) Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses. Virus Genes 21:13–25 (10.1023/A:1008135928310) / Virus Genes by HG Burgert (2000)
  25. Burgert H-G, Kvist S (1985) An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987–997 (10.1016/S0092-8674(85)80079-9) / Cell by HG Burgert (1985)
  26. Burgert H-G, Kvist S (1987) The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J 6:2019–2026 (10.1002/j.1460-2075.1987.tb02466.x) / Embo J by HG Burgert (1987)
  27. Burgert H-G, Maryanski JL, Kvist S (1987) “E3/19K” protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc Natl Acad Sci USA 84:1356–1360 (10.1073/pnas.84.5.1356) / Proc Natl Acad Sci USA by HG Burgert (1987)
  28. Carlin CR, Tollefson AE, Brady HA, Hoffman BL, Wold WS (1989) Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus. Cell 57: 135–144 (10.1016/0092-8674(89)90179-7) / Cell by CR Carlin (1989)
  29. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L (1997) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-KB pathway. Immunity 7:821–830 (10.1016/S1074-7613(00)80400-8) / Immunity by PM Chaudhary (1997)
  30. Chen MJ, Holskin B, Strickler J, Gorniak J, Clark MA, Johnson PJ, Mitcho M, Shalloway D (1987) Induction by El A oncogene expression of cellular susceptibility to lysis by TNF. Nature 330:581–583 (10.1038/330581a0) / Nature by MJ Chen (1987)
  31. Chen P, Tian J, Kovesdi I, Bruder JT (1998) Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis. J Biol Chem 273:5815–5820 (10.1074/jbc.273.10.5815) / J Biol Chem by P Chen (1998)
  32. Chen PH, Ornelles DA, Shenk T (1993) The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J Virol 67:3507–3514 (10.1128/JVI.67.6.3507-3514.1993) / J Virol by PH Chen (1993)
  33. Chinnadurai G (1998) Control of apoptosis by human adenovirus genes. Sem Virol 8:399–408 (10.1006/smvy.1997.0139) / Sem Virol by G Chinnadurai (1998)
  34. Chiou SK, White E (1997) p300 binding by El A cosegregates with p53 induction but is dispensable for apoptosis. J Virol 71:3515–3525 (10.1128/JVI.71.5.3515-3525.1997) / J Virol by SK Chiou (1997)
  35. Chroboczek J, Bieber F, Jacrot B (1992) The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186:280–285 (10.1016/0042-6822(92)90082-Z) / Virology by J Chroboczek (1992)
  36. Clarke P, Meintzer SM, Gibson S. Widmann C, Garrington TP, Johnson GL, Tyler KL (2000) Reovirus-induced apoptosis is mediated by TRAIL. J Virol 74:8135–8139 (10.1128/JVI.74.17.8135-8139.2000) / J Virol by P Clarke (2000)
  37. Clesham G, Adam P, Proudfoot D, Flynn P, Efstathiou S, Weissberg P (1998) High adenoviral loads stimulate NFicB-dependent gene expression in human vascular smooth muscle cells. Gene Ther 5:174–180 (10.1038/sj.gt.3300576) / Gene Ther by G Clesham (1998)
  38. Colonna M, Nakajima H, Cella M (2000) A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin Immunol 12:121 127 (10.1006/smim.2000.0214) / Semin Immunol by M Colonna (2000)
  39. Cook J, Potter T, Bellgrau D, Routes B (1996) El A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes. Oncogene 13:833–842 / Oncogene by J Cook (1996)
  40. Cook JL, Routes BA, Leu CY, Walker TA, Colvin KL (1999) E1A oncogene-induced cellular sensitization to immune-mediated apoptosis is independent of p53 and resistant to blockade by E1B 19kDa protein. Exp Cell Res 252:199–210 (10.1006/excr.1999.4617) / Exp Cell Res by JL Cook (1999)
  41. Coscoy L, Ganem D (2000) Kaposi’s sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA 97:8051–8056 (10.1073/pnas.140129797) / Proc Natl Acad Sci USA by L Coscoy (2000)
  42. Cosson P, Letourneur F (1994) Coatomer interaction with di-lysine endoplasmic reticulum retention motifs. Science 263:1629–1631 (10.1126/science.8128252) / Science by P Cosson (1994)
  43. Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR (1990) Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247:715–718 (10.1126/science.2137259) / Science by JH Cox (1990)
  44. Cress W, Nevins J (1996) Use of the E2F transcription factor by DNA tumor virus regulatory proteins. Curr Top Microbiol Immunol 208:63–78 / Curr Top Microbiol Immunol by W Cress (1996)
  45. Davison AJ, Telford EA, Watson MS, McBride K, Mautner V (1993) The DNA sequence of adenovirus type 40. J Mol Biol 234:1308–1316 (10.1006/jmbi.1993.1687) / J Mol Biol by AJ Davison (1993)
  46. Degli-Esposti M (1999) To die or not to die — the quest of the TRAIL receptors. J Leukoc Biol 65:535–542 (10.1002/jlb.65.5.535) / J Leukoc Biol by M Degli-Esposti (1999)
  47. De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW, Slaterus KW, Wertheim-Van Dillen P, Van Doornum GJ, Khoo SH, Hierholzer JC (1999) Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol 37:3940–3945 (10.1128/JCM.37.12.3940-3945.1999) / J Clin Microbiol by JC Jong De (1999)
  48. Deryckere F, Burgert H-G (1996a) Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgenera B and C. J Virol 70:2832–2841 (10.1128/JVI.70.5.2832-2841.1996) / J Virol by F Deryckere (1996)
  49. Deryckere F, Burgert H-G (1996b) Tumor necrosis factor alpha induces the adenovirus early 3 promoter by activation of NF-KB. J Biol Chem 271:30249–30255 (10.1074/jbc.271.47.30249) / J Biol Chem by F Deryckere (1996)
  50. Deryckere F, Ebenau-Jehle C, Wold WSM, Burgert H-G (1995) Tumor necrosis factor a increases expression of adenovirus E3 proteins. Immunobiol 193:186–192 (10.1016/S0171-2985(11)80542-5) / Immunobiol by F Deryckere (1995)
  51. Desagher S, Martinou J (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol 10:369–377 (10.1016/S0962-8924(00)01803-1) / Trends Cell Biol by S Desagher (2000)
  52. Desbarats J, Wade T, Wade WF, Newell MK (1999) Dichotomy between naive and memory CD4(+) T cell responses to Fas engagement. Proc Natl Acad Sci USA 96:8104–8109 (10.1073/pnas.96.14.8104) / Proc Natl Acad Sci USA by J Desbarats (1999)
  53. Dimitrov T, Krajcsi P, Hermiston TW, Tollefson AE, Hannink M, Wold WS (1997) Adenovirus E3–10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J Virol 71:2830–2837 (10.1128/JVI.71.4.2830-2837.1997) / J Virol by T Dimitrov (1997)
  54. Donze O, Dostie J, Sonenberg N (1999) Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and Fas receptor expression. Virology 256:322–329 (10.1006/viro.1999.9618) / Virology by O Donze (1999)
  55. Dragulev BP, Sira S, Abouhaidar MG, Campbell JB (1991) Sequence analysis of putative E3 and fiber genomic regions of two strains of canine adenovirus type 1. Virology 183:298–305 (10.1016/0042-6822(91)90142-X) / Virology by BP Dragulev (1991)
  56. Duerksen-Hughes P, Wold W, Gooding L (1989) Adenovirus El A renders infected cells sensitive to cytolysis by tumor necrosis factor. J Immunol 143:4193–1200 (10.4049/jimmunol.143.12.4193) / J Immunol by P Duerksen-Hughes (1989)
  57. Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383–424 (10.1146/annurev.biochem.68.1.383) / Annu Rev Biochem by WC Earnshaw (1999)
  58. Efrat S, Fejer G, Brownlee M, Horwitz MS (1995) Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc Natl Acad Sci USA 92:6947–6951 (10.1073/pnas.92.15.6947) / Proc Natl Acad Sci USA by S Efrat (1995)
  59. Elsing A, Burgert H-G (1998) The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc Natl Acad Sci USA 95:10072–10077 (10.1073/pnas.95.17.10072) / Proc Natl Acad Sci USA by A Elsing (1998)
  60. Fejer G, Gyory I, Tufariello J, Horwitz MS (1994) Characterization of transgenic mice containing adenovirus early region 3 genomic DNA. J Virol 68:5871–5881 (10.1128/JVI.68.9.5871-5881.1994) / J Virol by G Fejer (1994)
  61. Feuerbach D, Burgert H-G (1993) Novel proteins associated with MHC class I antigens in cells expressing the adenovirus protein E3/19K. EMBO J 12:3153–3161 (10.1002/j.1460-2075.1993.tb05984.x) / Embo J by D Feuerbach (1993)
  62. Feuerbach D, Etteldorf S, Ebenau-Jehle C, Abastado JP, Madden D, Burgert H-G (1994) Identification of amino acids within the MHC molecule important for the interaction with the adenovirus protein E3/19K. J Immunol 153:1626–1636 (10.4049/jimmunol.153.4.1626) / J Immunol by D Feuerbach (1994)
  63. Fletcher JM, Prentice HG, Grundy JE (1998) Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. J Immunol 161:2365–2374 (10.4049/jimmunol.161.5.2365) / J Immunol by JM Fletcher (1998)
  64. Flomenberg P, Gutierrez E, Hogan KT (1994) Identification of class I MHC regions which bind to the adenovirus E3–19k protein. Mol Immunol 31:1277–1284 (10.1016/0161-5890(94)90078-7) / Mol Immunol by P Flomenberg (1994)
  65. Flomenberg P, Piaskowski V, Truitt RL, Casper JT (1996) Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3–19K in the presence of gamma interferon. J Virol 70:6314–6322 (10.1128/JVI.70.9.6314-6322.1996) / J Virol by P Flomenberg (1996)
  66. Fox JP, Hall CE, Cooney MK (1977) The Seattle virus watch. VII Observations of adenovirus infections. Am J Epidemiol 105:362–386 (10.1093/oxfordjournals.aje.a112394) / Am J Epidemiol by JP Fox (1977)
  67. Gabathuler R, Kvist S (1990) The endoplasmic reticulum retention signal of the E3/19K protein of adenovirus type 2 consists of three separate amino acid segments at the carboxy terminus. J Cell Biol 111:1803–1810 (10.1083/jcb.111.5.1803) / J Cell Biol by R Gabathuler (1990)
  68. Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL, Wiley DC (2001) Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci USA 98:6794–6799 (10.1073/pnas.121172898) / Proc Natl Acad Sci USA by BE Gewurz (2001)
  69. Gil J, Esteban M (2000) The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-α receptors. Oncogene 19:3665–3674 (10.1038/sj.onc.1203710) / Oncogene by J Gil (2000)
  70. Ginsberg HS, Lundholm Beauchamp U, Horswood RL, Pernis B, Wold WS, Chanock RM, Prince G A (1989) Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci USA 86:3823–3827 (10.1073/pnas.86.10.3823) / Proc Natl Acad Sci USA by HS Ginsberg (1989)
  71. Ginsberg HS, Moldawer LL, Sehgal PB, Redington M, Kilian PL, Chanock RM. Prince GA (1991) A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 88:1651–1655 (10.1073/pnas.88.5.1651) / Proc Natl Acad Sci US by HS Ginsberg (1991)
  72. Goodbourn S, Didcock L, Randall RE (2000) Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81:2341–2364 (10.1099/0022-1317-81-10-2341) / J Gen Virol by S Goodbourn (2000)
  73. Gooding LR, Aquino L, Duerksen Hughes PJ, Day D, Horton TM, Yei SP, Wold WS (1991a) The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J Virol 65:3083 3094 (10.1128/JVI.65.6.3083-3094.1991) / J Virol by LR Gooding (1991)
  74. Gooding LR, Elmore LW, Tollefson AE. Brady HA, Wold WS (1988) A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341–346 (10.1016/0092-8674(88)90154-7) / Cell by LR Gooding (1988)
  75. Gooding LR, Ranheim TS, Tollefson AE, Aquino L, Duerksen-Hughes PJ, Horton TM, Wold WSM (1991b) The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J Virol 65:4114–4123 (10.1128/JVI.65.8.4114-4123.1991) / J Virol by LR Gooding (1991)
  76. Greber U, Suomalainen M, Stidwill R, Boucke K, Ebersold M, Helenius A (1997) The role of the nuclear pore complex in adenovirus DNA entry. EMBO J 16:5998–6007 (10.1093/emboj/16.19.5998) / Embo J by U Greber (1997)
  77. Hale T, Braithwaite A (1999) The adenovirus oncoprotein Ela stimulates binding of transcription factor ETF to transcriptionally activate the p53 gene. J Biol Chem 274:23777–23786 (10.1074/jbc.274.34.23777) / J Biol Chem by T Hale (1999)
  78. Harty JT, Tvinnereim AR, White DW (2000) CD8 + T cell effector mechanisms in resistance to infection. Annu Rev Immunol 18:275–308 (10.1146/annurev.immunol.18.1.275) / Annu Rev Immunol by JT Harty (2000)
  79. Hashimoto S, Ishii A, Yonehara S (1991) The Elb oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int Immunol 3:343–351 (10.1093/intimm/3.4.343) / Int Immunol by S Hashimoto (1991)
  80. Hatada EN, Krappmann D, Scheidereit C (2000) NF-KB and the innate immune response. Curr Opin Immunol 12:52–58 (10.1016/S0952-7915(99)00050-3) / Curr Opin Immunol by EN Hatada (2000)
  81. Hengel H, Brune W, Koszinowski UH (1998) Immune evasion by cytomegalovirus survival strategies of a highly adapted opportunist. Trends Microbiol 6:190–197 (10.1016/S0966-842X(98)01255-4) / Trends Microbiol by H Hengel (1998)
  82. Herissé J, Courtois G, Galibert F (1980) Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome. Nucleic Acids Res 8:2173–2192 (10.1093/nar/8.10.2173) / Nucleic Acids Res by J Herissé (1980)
  83. Herissé J, Galibert F (1981) Nucleotide sequence of the EcoRI E fragment of adenovirus 2 genome. Nucleic Acids Res 9:1229–1240 (10.1093/nar/9.5.1229) / Nucleic Acids Res by J Herissé (1981)
  84. Hermiston TW, Hellwig R, Hierholzer JC, Wold WS (1993) Sequence and functional analysis of the human adenovirus type 7 E3-gpl9K protein from 17 clinical isolates. Virology 197:593–600 (10.1006/viro.1993.1633) / Virology by TW Hermiston (1993)
  85. Hoffman P, Carlin C (1994) Adenovirus E3 protein causes constitutively internalized epidermal growth factor receptors to accumulate in a prelysosomal compartment, resulting in enhanced degradation. Mol Cell Biol 14:3695–3706 (10.1128/MCB.14.6.3695) / Mol Cell Biol by P Hoffman (1994)
  86. Hong JS, Mullis KG, Engler J A (1988) Characterization of the early region 3 and fiber genes of Ad7. Virology 167:545–553 (10.1016/S0042-6822(88)90117-1) / Virology by JS Hong (1988)
  87. Horton TM, Ranheim TS, Aquino L, Kusher DI, Saha SK, Ware CF, Wold WS, Gooding LR (1991) Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cvtolvsis. J Virol 65:2629–2639 (10.1128/JVI.65.5.2629-2639.1991) / J Virol by TM Horton (1991)
  88. Horton TM, Tollefson AE, Wold WS, Gooding LR (1990) A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes. J Virol 64:1250–1255 (10.1128/JVI.64.3.1250-1255.1990) / J Virol by TM Horton (1990)
  89. Horvath J, Palkonyay L, Weber J (1986) Group C adenovirus DNA sequences in human lymphoid cells. J Virol 59:189–192 (10.1128/JVI.59.1.189-192.1986) / J Virol by J Horvath (1986)
  90. Horwitz MS (1996) In: Fields BN, Knipe DM, Howley PM (eds) Adenoviruses. Lippincott-Raven Publishers, Philadelphia, New York, pp 2149–2171 / Adenoviruses by MS Horwitz (1996)
  91. Horwitz MS (2001) Adenovirus immunoregulatory genes and their cellular targets. Virology 279:1–8 (10.1006/viro.2000.0738) / Virology by MS Horwitz (2001)
  92. Huang DC, Cory S, Strasser A (1997) Bcl-2, Bcl-XL and adenovirus protein ElB19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14:405–414 (10.1038/sj.onc.1200848) / Oncogene by DC Huang (1997)
  93. Imperiale MJ, Akusjärvi G, Leppard KN (1995) Post-transcriptional control of adenovirus gene expression. Curr Top Microbiol Immunol 199/II:139–171 / Curr Top Microbiol Immunol by MJ Imperiale (1995)
  94. Ishido S, Wang C, Lee BS, Cohen GB, Jung JU (2000) Downregulation of major histocompatibility complex class I molecules by Kaposi’s sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74:5300–5309 (10.1128/JVI.74.11.5300-5309.2000) / J Virol by S Ishido (2000)
  95. Jackson MR, Nilsson T, Peterson PA (1990) Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J 9:3153–3162 (10.1002/j.1460-2075.1990.tb07513.x) / Embo J by MR Jackson (1990)
  96. Jackson MR, Nilsson T, Peterson PA (1993) Retrieval of transmembrane proteins to the endoplasmic reticulum. J Cell Biol 121:317–333 (10.1083/jcb.121.2.317) / J Cell Biol by MR Jackson (1993)
  97. Johnsen AC, Haux J, Steinkjer B, Nonstad U, Egeberg K, Sundan A, Ashkenazi A, Espevik T (1999) Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity. Cytokine 11:664–672 (10.1006/cyto.1999.0489) / Cytokine by AC Johnsen (1999)
  98. Jones N (1995) Transcriptional modulation by the adenovirus El A gene. Curr Top Microbiol Immunol 199 (Pt 3):59–80 / Curr Top Microbiol Immunol by N Jones (1995)
  99. Juang Y, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, Pitha PM (1998) Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sei USA 95:9837–9842 (10.1073/pnas.95.17.9837) / Proc Natl Acad Sei USA by Y Juang (1998)
  100. Kaplan JM, Armentano D, Scaria A, Woodworth LA, Pennington SE, Wadsworth SC, Smith AE, Gregory RJ (1999) Novel role for E4 region genes in protection of adenovirus vectors from lysis by cytotoxic T lymphocytes. J Virol 73:4489–4492 (10.1128/JVI.73.5.4489-4492.1999) / J Virol by JM Kaplan (1999)
  101. Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL (1999) Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol 163:5358–5366 (10.4049/jimmunol.163.10.5358) / J Immunol by Y Kashii (1999)
  102. Kasof G, Goyal L, White E (1999) Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins. Mol Cell Biol 19:4390–4404 (10.1128/MCB.19.6.4390) / Mol Cell Biol by G Kasof (1999)
  103. Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H (1999) Involvement of TNF-related apoptosis-inducing ligand in human CD4 + T cell-mediated cytotoxicity. J Immunol 162:2639–2647 (10.4049/jimmunol.162.5.2639) / J Immunol by N Kayagaki (1999)
  104. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P (1998) The death domain kinase RIP mediates the TNF-induced NF-KB signal. Immunity 8:297–303 (10.1016/S1074-7613(00)80535-X) / Immunity by MA Kelliher (1998)
  105. Kemp MC, Hierholzer JC, Cabradilla CP, Obijeski JF (1983) The changing etiology of epidemic keratoconjunctivitis: antigenic and restriction enzyme analyses of adenovirus types 19 and 37 isolated over a 10-year period. J Infect Dis 148:24–33 (10.1093/infdis/148.1.24) / J Infect Dis by MC Kemp (1983)
  106. Kirchhausen T (1999) Adaptors for clathrin-mediated traffic. Annu Rev Cell Dev Biol 15:705–732 (10.1146/annurev.cellbio.15.1.705) / Annu Rev Cell Dev Biol by T Kirchhausen (1999)
  107. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A (2000) Apo2L/TRAIL-cdependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611–620 (10.1016/S1074-7613(00)80212-5) / Immunity by FC Kischkel (2000)
  108. Kitajewski J, Schneider R, Safer B, Munemitsu S, Samuel C, Thimmappaya B, Shenk T (1986) Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 45:195–200 (10.1016/0092-8674(86)90383-1) / Cell by J Kitajewski (1986)
  109. Körner H, Burgert H-G (1994) Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. J Virol 68:1442–1448 (10.1128/JVI.68.3.1442-1448.1994) / J Virol by H Körner (1994)
  110. Körner H, Fritzsche U, Burgert H-G (1992) Tumor necrosis factor alpha stimulates expression of adenovirus early region 3 proteins: implications for viral persistence. Proc Natl Acad Sei USA 89:11857–11861 (10.1073/pnas.89.24.11857) / Proc Natl Acad Sei USA by H Körner (1992)
  111. Kos FJ, Engleman EG (1996) Immune regulation: a critical link between NK cells and CTLs. Immunol Today 17:174–176 (10.1016/0167-5699(96)80616-5) / Immunol Today by FJ Kos (1996)
  112. Krajcsi P, Dimitrov T, Hermiston TW, Tollefson AE, Ranheim TS, Vande Pol SB, Stephenson AH, Wold WS (1996) The adenovirus E3–14.7K protein and the E3–10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J Virol 70:4904–4913 (10.1128/JVI.70.8.4904-4913.1996) / J Virol by P Krajcsi (1996)
  113. Krajcsi P, Wold WS (1992) The adenovirus E3–14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine. Virology 187:492–498 (10.1016/0042-6822(92)90451-T) / Virology by P Krajcsi (1992)
  114. Kratzer F, Rosorius O, Heger P, Hirschmann N, Dobner T, Hauber J, Stauber R (2000) The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 17:850–857 (10.1038/sj.onc.1203395) / Oncogene by F Kratzer (2000)
  115. Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC (1998) E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol 140:637–645 (10.1083/jcb.140.3.637) / J Cell Biol by JN Lavoie (1998)
  116. Lee MG, Abina MA, Haddada H, Perricaudet M (1995) The constitutive expression of the immunomodulatory gpl9k protein in El(-), E3(-) adenoviral vectors strongly reduces the host cytotoxic T-cell response against the vector. Gene Ther 2:256–262 / Gene Ther by MG Lee (1995)
  117. Leonard G, Sen G (1996) Effects of adenovirus El A protein on interferon-signaling. Virology 224:25–33 (10.1006/viro.1996.0503) / Virology by G Leonard (1996)
  118. Leonard GT, Sen GC (1997) Restoration of interferon responses of adenovirus ElA-expressing HT1080 cell lines by overexpression of p48 protein. J Virol 71:5095–5101 (10.1128/JVI.71.7.5095-5101.1997) / J Virol by GT Leonard (1996)
  119. Li Y, Kang J, Friedman J, Tarassishin L, Ye J, Kovalenko A, Wallach D, Horwitz MS (1999) Identification of a cell protein (FIP-3) as a modulator of NF-KB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc Natl Acad Sci USA 96:1042–1047 (10.1073/pnas.96.3.1042) / Proc Natl Acad Sci USA by Y Li (1999)
  120. Li Y, Kang J, Horwitz MS (1997) Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers. J Virol 71:1576–1582 (10.1128/JVI.71.2.1576-1582.1997) / J Virol by Y Li (1997)
  121. Li Y, Kang J, Horwitz MS (1998) Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor oc-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 18:1601–1610 (10.1128/MCB.18.3.1601) / Mol Cell Biol by Y Li (1998)
  122. Lieber A, He C, Meuse L, Himeda C, Wilson C, Kay M (1998) Inhibition of NF-KB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver. J Virol 72:9267–9277 (10.1128/JVI.72.11.9267-9277.1998) / J Virol by A Lieber (1998)
  123. Lobigs M, Chelvanayagam G, Mullbacher A (2000) Proteolytic processing of peptides in the lumen of the endoplasmic reticulum for antigen presentation by major histocompatibility class I. Eur J Immunol 30:1496–1506 (10.1002/(SICI)1521-4141(200005)30:5<1496::AID-IMMU1496>3.0.CO;2-6) / Eur J Immunol by M Lobigs (2000)
  124. Look D, Roswit W, Frick A, Gris-Alevy Y, Dickhaus D, Walter M, Holtzman M (1998) Direct suppression of Statl function during adenoviral infection. Immunity 9:871–880 (10.1016/S1074-7613(00)80652-4) / Immunity by D Look (1998)
  125. Ma Y, Mathews MB (1996) Structure, function, and evolution of adenovirus-associated RNA: a phy-logenetic approach. J Virol 70:5083–5099 (10.1128/JVI.70.8.5083-5099.1996) / J Virol by Y Ma (1996)
  126. Mahr JA, Gooding LR (1999) Immune evasion by adenoviruses. Immunol Rev 168:121–130 (10.1111/j.1600-065X.1999.tb01287.x) / Immunol Rev by JA Mahr (1999)
  127. Marcellus RC, Lavoie JN, Boivin D, Shore GC, Ketner G, Branton PE (1998) The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis. J Virol 72:7144–7153 (10.1128/JVI.72.9.7144-7153.1998) / J Virol by RC Marcellus (1998)
  128. Marks MS, Ohno H, Kirchhausen T, Bonifacino JS (1997) Protein sorting by tyrosine-based signals: adapting to the Ys and wherefores. Trends Cell Biol 7:124–128 (10.1016/S0962-8924(96)10057-X) / Trends Cell Biol by MS Marks (1997)
  129. Martin M, Berk A (1999) Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription. Mol Cell Biol 19:3403–3414 (10.1128/MCB.19.5.3403) / Mol Cell Biol by M Martin (1999)
  130. Matsuse T, Hayashi S, Kuwano K, Keunecke H, JefTeries WA, Hogg JC (1992) Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 146:177–184 (10.1164/ajrccm/146.1.177) / Am Rev Respir Dis by T Matsuse (1992)
  131. Mei YF, Wadell G (1992) The nucleotide sequence of adenovirus type 11 early 3 region: comparison of genome type Ad11p and Ad 11a. Virology 191:125–133 (10.1016/0042-6822(92)90173-M) / Virology by YF Mei (1992)
  132. Moretta A, Biassoni R, Bottino C, Moretta L (2000) Surface receptors delivering opposite signals regulate the function of human NK cells. Semin Immunol 12:129–138 (10.1006/smim.2000.0215) / Semin Immunol by A Moretta (2000)
  133. Moriishi K, Huang DC, Cory S, Adams JM (1999) Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. Proc Natl Acad Sci USA 96:9683–9688 (10.1073/pnas.96.17.9683) / Proc Natl Acad Sci USA by K Moriishi (1999)
  134. Nagata S (1997) Apoptosis by death factor. Cell 88:355–365 (10.1016/S0092-8674(00)81874-7) / Cell by S Nagata (1997)
  135. Nemerow GR (2000) Cell receptors involved in adenovirus entry. Virology 274:1–4 (10.1006/viro.2000.0468) / Virology by GR Nemerow (2000)
  136. Nemerow GR, Stewart PL (1999) Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 63:725–734 (10.1128/MMBR.63.3.725-734.1999) / Microbiol Mol Biol Rev by GR Nemerow (1999)
  137. Neumann R, Genersch E, Eggers HJ (1987) Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res 7:93–97 (10.1016/0168-1702(87)90060-8) / Virus Res by R Neumann (1987)
  138. Ng F, Nguyen M, Kwan T, Branton P, Nicholson D, Cromlish J, Shore G (1997) p28 Bap31, a Bcl-2/Bcl-XL and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol 139:327–338 (10.1083/jcb.139.2.327) / J Cell Biol by F Ng (1997)
  139. Nguyen M, Branton P, Roy S, Nicholson D, Alnemri E, Yeh W, Mak T, Shore G (1998) ElA-induced processing of procaspase-8 can occur independently of FADD and is inhibited by Bcl-2. J Biol Chem 273:33099–33102 (10.1074/jbc.273.50.33099) / J Biol Chem by M Nguyen (1998)
  140. Nielsen H, Engelbrecht J, Brunak S, von Heijne G (1997) Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 10:1–6 (10.1093/protein/10.1.1) / Protein Eng by H Nielsen (1997)
  141. O’Brien V (1998) Viruses and apoptosis. J Gen Virol 79:1833–1845 (10.1099/0022-1317-79-8-1833) / J Gen Virol by V O’Brien (1998)
  142. Pääbo S, Nilsson T, Peterson PA (1986a) Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci USA 83: 9665–9669 (10.1073/pnas.83.24.9665) / Proc Natl Acad Sci USA by S Pääbo (1986)
  143. Pääbo S, Weber F, Nilsson T, Schaffner W, Peterson PA (1986b) Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J 5:1921–1927 (10.1002/j.1460-2075.1986.tb04445.x) / Embo J by S Pääbo (1986)
  144. Pamer E, Cresswell P (1998) Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 16:323–358 (10.1146/annurev.immunol.16.1.323) / Annu Rev Immunol by E Pamer (1998)
  145. Perez D, White E (1998) E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE. J Biol Chem 141:1255–1266 / J Biol Chem by D Perez (1998)
  146. Perez D, White E (2000) TNF-α signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol Cell 6:53–63 (10.1016/S1097-2765(05)00013-4) / Mol Cell by D Perez (2000)
  147. Philipson L (1984) In: Ginsberg HS (ed) Adenovirus Assembly. Plenum Press, New York, pp 309–337 (10.1007/978-1-4684-7935-5_8) / Adenovirus Assembly by L Philipson (1984)
  148. Ranheim TS, Shisler J, Horton TM, Wold LJ, Gooding LR, Wold WS (1993) Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. J Virol 67:2159–2167 (10.1128/JVI.67.4.2159-2167.1993) / J Virol by TS Ranheim (1993)
  149. Rao L, Modha D, White E (1997) The E1B 19K protein associates with lamins in vivo and its proper localization is required for inhibition of apoptosis. Oncogene 15:1587–1597 (10.1038/sj.onc.1201323) / Oncogene by L Rao (1997)
  150. Raska KJ, Gallimore PH (1982) An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology 123:8–18 (10.1016/0042-6822(82)90290-2) / Virology by KJ Raska (1982)
  151. Reich N, Pine R, Levy D, Darnell JJ (1988) Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by El A gene products. J Virol 62:114–119 (10.1128/JVI.62.1.114-119.1988) / J Virol by N Reich (1988)
  152. Reits EA, Vos JC, Gromme M, Neefjes J (2000) The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404:774–778 (10.1038/35008103) / Nature by EA Reits (2000)
  153. Roelvink PW, Lizonova A, Lee JGM, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ (1998) The coxsackievirus-adenovirus receptor protein can function as a Cellular attachment protein for adenovirus serotypes from subgenera A, C, D, E, and F. J Virol 72: 7909–7915 (10.1128/JVI.72.10.7909-7915.1998) / J Virol by PW Roelvink (1998)
  154. Roelvink PW, Mi Lee G, Einfeld DA, Kovesdi I, Wickham TJ (1999) Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286:1568–1571 (10.1126/science.286.5444.1568) / Science by PW Roelvink (1999)
  155. Routes J, Ryan S, Clase A, Miura T, Kuhl A, Potter T, Cook J (2000) Adenovirus El A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand. J Immunol 165:4522–4527 (10.4049/jimmunol.165.8.4522) / J Immunol by J Routes (2000)
  156. Routes JM, Cook JL (1995) El A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus infection of human cells. Virology 210:421–428 (10.1006/viro.1995.1358) / Virology by JM Routes (1995)
  157. Rowe WP, Huebner RJ, Gillmore LK, Parrott RH, Ward TG (1953) Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84:570 (10.3181/00379727-84-20714) / Proc Soc Exp Biol Med by WP Rowe (1953)
  158. Russell WC (2000) Update on adenovirus and its vectors. J Gen Virol 81:2573–2604 (10.1099/0022-1317-81-11-2573) / J Gen Virol by WC Russell (2000)
  159. Sandoval IV, Bakke O (1994) Targeting of membrane proteins to endosomes and lysosomes. Trends Cell Biol 4:292–297 (10.1016/0962-8924(94)90220-8) / Trends Cell Biol by IV Sandoval (1994)
  160. Schmitz M, Indorf A, Limbourg F, Stadtler H, Traenckner E, Baeuerle P (1996) The dual effect of adenovirus type 5 El A 13 S protein on NF-kappaB activation is antagonized by E1B 19K. Mol Cell Biol 16:4052–4063 (10.1128/MCB.16.8.4052) / Mol Cell Biol by M Schmitz (1996)
  161. Schouten GJ, van der Eb AJ, Zantema A (1995) Downregulation of MHC class I expression due to interference with pl05-NF kappa B1 processing by Adl2El A. EMBO J 14:1498–1507 (10.1002/j.1460-2075.1995.tb07136.x) / Embo J by GJ Schouten (1995)
  162. Schowalter DB, Tubb JC, Liu M, Wilson CB, Kay MA (1997) Heterologous expression of adenovirus E3-gpl9K in an Ela-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo. Gene Ther 4:351–360 (10.1038/sj.gt.3300398) / Gene Ther by DB Schowalter (1997)
  163. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770–774 (10.1038/35008096) / Nature by U Schubert (2000)
  164. Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D, Wiley SR (1999) IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol 163:920–926 (10.4049/jimmunol.163.2.920) / J Immunol by LM Sedger (1999)
  165. Sester M, Burgert H-G (1994) Conserved cysteine residues within the E3/19K protein of adenovirus type 2 are essential for binding to major histocompatibility complex antigens. J Virol 68:5423–5432 (10.1128/JVI.68.9.5423-5432.1994) / J Virol by M Sester (1994)
  166. Sester M, Feuerbach D, Frank R, Preckel T, Gutermann A, Burgert H-G (2000) The amyloid precursorlike protein 2 associates with the major histocompatibility complex class i molecule Kd. J Biol Chem 275:3645–3654 (10.1074/jbc.275.5.3645) / J Biol Chem by M Sester (2000)
  167. Shao R, Hu M, Zhou B, Lin S, Chiao P, von Lindern R, Spohn B, Hung M (1999) E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IKB kinases and nuclear factor kB activities. J Biol Chem 274:21495–21498 (10.1074/jbc.274.31.21495) / J Biol Chem by R Shao (1999)
  168. Shenk T (1996) In: Fields BN, Knipe DM, Howley PM (eds), Adenoviridae: the Viruses and their replication. Lippincott-Raven Publishers, Philadelphia, New York, pp 2111–2148 / Adenoviridae: the Viruses and their replication by T Shenk (1996)
  169. Shisler J, Duerksen-Hughes P, Hermiston T, Wold W, Gooding L (1996) Induction of susceptibility to tumor necrosis factor by El A is dependent on binding to either p300 or pl05-Rb and induction of DNA synthesis. J Virol 70:68–77 (10.1128/JVI.70.1.68-77.1996) / J Virol by J Shisler (1996)
  170. Shisler J, Yang C, Walter B, Ware CF, Gooding LR (1997) The adenovirus E3–10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J Virol 71: 8299–8306 (10.1128/JVI.71.11.8299-8306.1997) / J Virol by J Shisler (1997)
  171. Signäs C, Akusjärvi G, Pettersson U (1986) Region E3 of human adenoviruses; differences between the oncogenic adenovirus-3 and the non-oncogenic adenovirus-2. Gene 50:173–184 (10.1016/0378-1119(86)90322-7) / Gene by C Signäs (1986)
  172. Spiliotis ET, Osorio M, Zuniga MC, Edidin M (2000) Selective export of MHC class I molecules from the ER after their dissociation from TAP. Immunity 13:841–851 (10.1016/S1074-7613(00)00081-9) / Immunity by ET Spiliotis (2000)
  173. Sprengel J, Schmitz B, Heuss Neitzel D, Zock C, Doerfler W (1994) Nucleotide sequence of human adenovirus type 12 DNA: comparative functional analysis. J Virol 68:379–389 (10.1128/JVI.68.1.379-389.1994) / J Virol by J Sprengel (1994)
  174. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH, Walczak H (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12:599–609 (10.1016/S1074-7613(00)80211-3) / Immunity by MR Sprick (2000)
  175. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227–264 (10.1146/annurev.biochem.67.1.227) / Annu Rev Biochem by GR Stark (1998)
  176. Stevenson PG, Efstathiou S, Doherty PC, Lehner PJ (2000) Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sei USA 97:8455–8460 (10.1073/pnas.150240097) / Proc Natl Acad Sei USA by PG Stevenson (2000)
  177. Stewart AR, Tollefson AE, Krajcsi P, Yei SP, Wold WS (1995) The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane. J Virol 69:172–181 (10.1128/JVI.69.1.172-181.1995) / J Virol by AR Stewart (1995)
  178. Straus SE (1984) In: Ginsberg HS (ed) Adenovirus infections in humans. Plenum Press, New York and London, pp 451–496 / Adenovirus infections in humans by SE Straus (1984)
  179. Teasdale RD, Jackson MR (1996) Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Annu Rev Cell Dev Biol 12:27–54 (10.1146/annurev.cellbio.12.1.27) / Annu Rev Cell Dev Biol by RD Teasdale (1996)
  180. Teodoro JG, Branton PE (1997) Regulation of apoptosis by viral gene products. J Virol 71:1739–1746 (10.1128/JVI.71.3.1739-1746.1997) / J Virol by JG Teodoro (1997)
  181. Teodoro JG, Shore GC, Branton PE (1995) Adenovirus El A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene 11:467–474 / Oncogene by JG Teodoro (1995)
  182. Thomas A, White E (1998) Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev 12:1975–1985 (10.1101/gad.12.13.1975) / Genes Dev by A Thomas (1998)
  183. Thorne TE, Voelkel Johnson C, Casey WM, Parks LW, Laster SM (1996) The activity of cytosolic phospholipase A2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor. J Virol 70:8502–8507 (10.1128/JVI.70.12.8502-8507.1996) / J Virol by TE Thorne (1996)
  184. Tollefson AE, Hermiston TW, Lichtenstein DL, Colle CF, Tripp RA, Dimitrov T, Toth K, Wells CE, Doherty PC, Wold WS (1998) Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392:726–730 (10.1038/33712) / Nature by AE Tollefson (1998)
  185. Tollefson AE, Scaria A, Hermiston T, Ryerse JS, Wold LJ, Wold WSM (1996) The adenovirus death protein (E3–11.6K) is required at very late stages of infection for efficient cell-lysis and release of adenovirus from infected-cells. J Virol 70:2296–2306 (10.1128/JVI.70.4.2296-2306.1996) / J Virol by AE Tollefson (1996)
  186. Tollefson AE, Stewart AR, Yei SP, Saha SK, Wold WS (1991) The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J Virol 65:3095–3105 (10.1128/JVI.65.6.3095-3105.1991) / J Virol by AE Tollefson (1991)
  187. Tomko RP, Xu R, Philipson L (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sei USA 94: 3352–3356 (10.1073/pnas.94.7.3352) / Proc Natl Acad Sei USA by RP Tomko (1997)
  188. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL (2000) Viral subversion of the immune system. Annu Rev Immunol 18:861–926 (10.1146/annurev.immunol.18.1.861) / Annu Rev Immunol by D Tortorella (2000)
  189. Trapani JA, Davis J, Sutton VR, Smyth MJ (2000) Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol 12:323–329 (10.1016/S0952-7915(00)00094-7) / Curr Opin Immunol by JA Trapani (2000)
  190. Tufariello J, Cho S, Horwitz MS (1994) The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. J Virol 68:453–462 (10.1128/JVI.68.1.453-462.1994) / J Virol by J Tufariello (1994)
  191. Turnell A, Grand R, Gorbea C, Zhang X, Wang W, Mymryk J, Gallimore P (2000) Regulation of the 26 S proteasome by adenovirus E1A. EMBO J 19:4759–1773 (10.1093/emboj/19.17.4759) / Embo J by A Turnell (2000)
  192. van Endert PM (1999) Genes regulating MHC class I processing of antigen. Curr Opin Immunol 11:82–88 (10.1016/S0952-7915(99)80015-6) / Curr Opin Immunol by PM Endert van (1999)
  193. Vandenabeele P, Declercq W, Beyart R, Fiers W (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 5:392–399 (10.1016/S0962-8924(00)89088-1) / Trends Cell Biol by P Vandenabeele (1995)
  194. Vidalain P-O, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C, Servet-Delprat C (2000) Measles virus induces functional TRAIL production by human dendritic cells. J Virol 74:556–559 (10.1128/JVI.74.1.556-559.2000) / J Virol by PO Vidalain (2000)
  195. von Herrath MG, Efrat S, Oldstone MB, Horwitz MS (1997) Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. Proc Natl Acad Sci USA 94:9808–9813 (10.1073/pnas.94.18.9808) / Proc Natl Acad Sci USA by MG Herrath von (1997)
  196. Wadell G (1990) In: Zuckerman AJ, Banatvala JE, Pattison JR (eds) Adenoviruses. Wiley, New York, pp 267–297 / Adenoviruses by G Wadell (1990)
  197. Walczak H, Krammer PH (2000) The CD95 (APO-l/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256:58–66 (10.1006/excr.2000.4840) / Exp Cell Res by H Walczak (2000)
  198. Wallach D (1997) Cell death induction by TNF: a matter of self control. Trends Biochem Sci 22:107–109 (10.1016/S0968-0004(97)01015-3) / Trends Biochem Sci by D Wallach (1997)
  199. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331–367 (10.1146/annurev.immunol.17.1.331) / Annu Rev Immunol by D Wallach (1999)
  200. White E (1998) Regulation of apoptosis by adenovirus E1A and E1B oncogenes. Semin Virol 8:505–513 (10.1006/smvy.1998.0155) / Semin Virol by E White (1998)
  201. White E, Faha B, Stillman B (1986) Regulation of adenovirus gene expression in human WI38 cells by an ElB-encoded tumor antigen. Mol Cell Biol 6:3763–3773 (10.1128/MCB.6.11.3763) / Mol Cell Biol by E White (1986)
  202. Wickham T, Mathias P, Cheresh D, Nemerow G (1993) Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309–319 (10.1016/0092-8674(93)90231-E) / Cell by T Wickham (1993)
  203. Wienzek S, Roth J, Dobbelstein M (2000) E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51or p73, and cooperate with E4orf6 proteins to destabilize p53. J Virol 74:193–202 (10.1128/JVI.74.1.193-202.2000) / J Virol by S Wienzek (2000)
  204. Williams BR (1999) PKR; a sentinel kinase for cellular stress. Oncogene 18:6112–6120 (10.1038/sj.onc.1203127) / Oncogene by BR Williams (1999)
  205. Williams JL, Garcia J, Harrich D, Pearson L, Wu F, Gaynor R (1990) Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-K B binding motifs. EMBO J 9:4435–4442 (10.1002/j.1460-2075.1990.tb07894.x) / Embo J by JL Williams (1990)
  206. Wilson-Rawls J, Wold WS (1993) The E3–6.7K protein of adenovirus is an Asn-linked integral membrane glycoprotein localized in the endoplasmic reticulum. Virology 195:6–15 (10.1006/viro.1993.1341) / Virology by J Wilson-Rawls (1993)
  207. Wissing D, Mouritzen H, Egeblad M, Poirier GG, Jäättelä M (1997) Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci USA 94:5073–5077 (10.1073/pnas.94.10.5073) / Proc Natl Acad Sci USA by D Wissing (1997)
  208. Wold WSM, Hermiston TW, Tollefson AE (1995) E3 transcription unit of adenovirus. Curr Top Microbiol Immunol 199/1:237–274 / Curr Top Microbiol Immunol by WSM Wold (1995)
  209. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, Israel A (1998) Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-KB activation. Cell 93:1231–1240 (10.1016/S0092-8674(00)81466-X) / Cell by S Yamaoka (1998)
  210. Yeh HY, Pieniazek N, Pieniazek D, Luftig RB (1996) Genetic organization, size, and complete sequence of early region-3 genes of human adenovirus type-41. J Virol 70:2658–2663 (10.1128/JVI.70.4.2658-2663.1996) / J Virol by HY Yeh (1996)
  211. Yewdell JW, Bennink JR (1999) Mechanisms of viral interference with MHC class I antigen processing and presentation. Annu Rev Cell Dev Biol 15:579–606 (10.1146/annurev.cellbio.15.1.579) / Annu Rev Cell Dev Biol by JW Yewdell (1999)
  212. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B (1998) Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 188:2375–2380 (10.1084/jem.188.12.2375) / J Exp Med by L Zamai (1998)
  213. Zhang J, Vinkemeier U, Gu W, Chakravarti D, Horvath C, Darnell JJ (1996) Two contact regions between Statl and CBP/p300 in interferon gamma signaling. Proc Natl Acad Sci USA 93:15092–15096 (10.1073/pnas.93.26.15092) / Proc Natl Acad Sci USA by J Zhang (1996)
Dates
Type When
Created 13 years, 11 months ago (Sept. 16, 2011, 2:47 a.m.)
Deposited 2 years, 2 months ago (June 9, 2023, 11:54 a.m.)
Indexed 11 months, 4 weeks ago (Sept. 6, 2024, 3:59 a.m.)
Issued 23 years, 8 months ago (Jan. 1, 2002)
Published 23 years, 8 months ago (Jan. 1, 2002)
Published Print 23 years, 8 months ago (Jan. 1, 2002)
Funders 0

None

@inbook{Burgert_2002, title={Subversion of Host Defense Mechanisms by Adenoviruses}, ISBN={9783642594212}, ISSN={0070-217X}, url={http://dx.doi.org/10.1007/978-3-642-59421-2_16}, DOI={10.1007/978-3-642-59421-2_16}, booktitle={Viral Proteins Counteracting Host Defenses}, publisher={Springer Berlin Heidelberg}, author={Burgert, H.-G. and Ruzsics, Z. and Obermeier, S. and Hilgendorf, A. and Windheim, M. and Elsing, A.}, year={2002}, pages={273–318} }